Impact of HIV genotyping and drug levels on the response to salvage therapy with saquinavir/ritonavir

This publication has 19 references indexed in Scilit:

• Ritonavir-Saquinavir Dual Protease Inhibitor Compared to Ritonavir Alone in Human Immunodeficiency Virus-Infected Patients
  Antimicrobial Agents and Chemotherapy, 2001
• Saquinavir and ritonavir pharmacokinetics following combined ritonavir and saquinavir (soft gelatin capsules) administration
  British Journal of Clinical Pharmacology, 2001
• Steady-State Pharmacokinetics of Twice-Daily Dosing of Saquinavir Plus Ritonavir in HIV-1–Infected Individuals
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
• Antiretroviral Resistance Mutations Revised April 2001
  HIV Research & Clinical Practice, 2001
• A Phase II Trial of Dual Protease Inhibitor Therapy: Amprenavir in Combination With Indinavir, Nelfinavir, or Saquinavir
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
• Antiretroviral Drug Resistance Testing in Adult HIV-1 Infection
  JAMA, 2000
• What dual protease inhibitor combination for salvage therapies?
  AIDS, 1999
• Virologic responses to a ritonavir-saquinavir-containing regimen in patients who had previously failed nelfinavir
  AIDS, 1999
• Activity of a ritonavir plus saquinavir-containing regimen in patients with virologic evidence of indinavir or ritonavir failure
  AIDS, 1998
• Pharmacokinetic interactions between two human immunodeficiency virus protease inhibitors, ritonavir and saquinavir*
  Clinical Pharmacology & Therapeutics, 1998